aid: neurelis
name: Neurelis
description: 'Neurelis, Inc. is a privately held San Diego neuroscience and specialty
  pharmaceutical company founded in 2007 that licenses, develops and commercializes
  therapies for epilepsy, psychiatry and other central nervous system disorders with
  high unmet need. Its lead commercial product is VALTOCO (diazepam nasal spray), an
  FDA-approved acute treatment for intermittent, stereotypic episodes of frequent seizure
  activity (seizure clusters) in adult and pediatric patients two years of age and older,
  built on Intravail transmucosal absorption-enhancement technology acquired with Aegis
  Therapeutics. Neurelis also holds the ProTek and Hydrogel drug-delivery platforms,
  licenses Intravail to partners such as ARS Pharmaceuticals and Dr. Reddy''s/Upsher-Smith,
  and is advancing the NRL-1049 and NRL-1004 pipeline programs. Neurelis publishes no
  developer program, no public API and no machine-readable API contract; its only
  agent-facing machine-readable surface is a set of llms.txt documents served on its
  corporate, product and patient-support properties.'
url: https://raw.githubusercontent.com/api-evangelist/neurelis/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: "Neurelis publishes no developer program, no public API and no machine-readable API contract; its only agent-facing machine-readable surface is a set of llms.txt documents served on its corporate, prod"
x-type: company
x-source: harvest:secondary-market
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Pharmaceuticals
- Life Sciences
- Healthcare
- Neuroscience
- Epilepsy
- Drug Delivery
- Specialty Pharma
- Biotechnology
image: https://www.neurelis.com/wp-content/uploads/2024/11/Neurelis_Logo1-1.png
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/neurelis-domain-security.yml
- type: Website
  url: https://www.neurelis.com/
- type: About
  url: https://www.neurelis.com/about-neurelis/
- type: Blog
  url: https://www.neurelis.com/neurelis-news/
- type: Support
  url: https://www.neurelis.com/contact-us/
- type: TermsOfService
  url: https://www.neurelis.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.neurelis.com/privacy-policy/
- type: SignUp
  url: https://www.neurelis.com/neurelis-news/signup/
- type: LLMsTxt
  url: llms/neurelis-llms.txt
- type: LLMsTxt
  url: llms/neurelis-valtoco-llms.txt
- type: LLMsTxt
  url: llms/neurelis-myneurelis-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Neurelis is a San Diego specialty pharmaceutical manufacturer whose product is a
    prescription nasal spray, not software — there is no developer subdomain in DNS
    (api., developer., docs. and portal.neurelis.com all fail to resolve), no GitHub
    organization, and every OpenAPI/Swagger/GraphQL/.well-known path probed across
    neurelis.com, valtoco.com, myneurelis.com and intravail.com returned 404.
  evidence:
  - url: https://www.neurelis.com/openapi.json
    status: 404
  - url: https://www.neurelis.com/.well-known/agent-card.json
    status: 404
  - url: https://api.github.com/orgs/neurelis
    status: 404
  - url: https://www.neurelis.com/llms.txt
    status: 200
  checked: '2026-08-26'